Literature DB >> 6183754

Prostatism and inguinal hernia.

I M Thompson, C A Wesen.   

Abstract

We reviewed a series of 70 patients who had transurethral resection of the prostate to determine the incidence of inguinal hernia. We found inguinal hernias in 20% of the patients, a figure significantly higher than in the general population. In 47% of the patients a hernia was present on admission or herniorrhaphy had been done previously. Urine flow rate has been previously found to be an excellent screening measurement for prostatism, a concept confirmed by this series. Because benign prostatic hyperplasia has associated morbidity and because its presence is not desirable in patients having herniorrhaphy, urine flow rate is advocated as a routine screening test for prostatism in patients with inguinal hernias.

Entities:  

Mesh:

Year:  1982        PMID: 6183754     DOI: 10.1097/00007611-198211000-00009

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Is there a difference in early perioperative morbidity in transurethral resection of prostate (TURP) versus TURP with cystolitholapaxy and TURP with inguinal herniorrhaphy?

Authors:  M Hammad Ather; Nuzhat Faruqui; Fuad Abid; M Nasir Sulaiman
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Combined transurethral prostatectomy and inguinal hernioplasty.

Authors:  I Othman; A-F Abdel-Maguid
Journal:  Hernia       Date:  2009-11-01       Impact factor: 4.739

3.  Concurrent laparoscopic totally extraperitoneal inguinal hernia repair and transurethral resection of prostate: Breaking with convention - A retrospective study.

Authors:  Rafique Umer Harvitkar; Prakash Chandra Shetty; Abhijit Joshi
Journal:  J Minim Access Surg       Date:  2022 Jan-Mar       Impact factor: 1.407

4.  Lower urinary tract symptoms-Benign prostatic hyperplasia may increase the risk of subsequent inguinal hernia in a Taiwanese population: A nationwide population-Based cohort study.

Authors:  Yi-Hsuan Wu; Yung-Shun Juan; Jung-Tsung Shen; Hsun-Shuan Wang; Jhen-Hao Jhan; Yung-Chin Lee; Jiun-Hung Geng
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.